SEATTLE, April 7, 2021 /PRNewswire/ -- CTI BioPharma Corp. CTIC today announced that management will provide a corporate overview at the 20th Annual Needham Virtual Healthcare Conference at 3:00 p.m. EST. The conference will be held in a virtual meeting format.
Presentation details:
Event: 20th Annual Needham Virtual Healthcare Conference
Date: Wednesday, April 14, 2021
Time: 3:00 p.m. EST
The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.
About CTI BioPharma Corp.
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. In addition, we have recently started developing pacritinib for use in hospitalized patients with severe COVID-19, in response to the COVID-19 pandemic. We are headquartered in Seattle, Washington.
CTI BioPharma Investor Contacts:
Maghan Meyers
+212-600-1902
View original content to download multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-20th-annual-needham-virtual-healthcare-conference-on-wednesday-apr-14-301263743.html
SOURCE CTI BioPharma Corp.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.